Gursaran Talwar

Gursaran Prasad ("Pran") Talwar (born 2 October 1926[1]) is an Indian medical researcher who is known for developing vaccines and immunocontraceptions.[2][3] His discovery of a unique strain of bacterium, eponymously named Mycobacterium indicus pranii (MIP) led to the development of the first leprosy vaccine (commonly called MIP vaccine) in the world.[4] He is most popularly known for his founding of the National Institute of Immunology, an autonomous research institute of the government of India, and the Talwar Foundation, a non-governmental organisation for continuing research in vaccines.[5]

Biography

In a 1994 paper,[6] his group demonstrated that women could be vaccinated to prevent pregnancy. Gursaran Prasad Talwar received BSc (Hons) and MSc (Tech) degrees from the University of Punjab, DSc from Sorbonne working at the Institut Pasteur, Paris and DSc (hc) from Bundhelkhand University (2004). He was Alexander von Humboldt Postdoctoral Fellow at Tübingen, Stuttgart and Munich. He joined as associate professor of biochemistry (1956) in the newly created All India Institute of Medical Sciences (AIIMS), New Delhi, and also worked there as Professor and Head till 1983. He was Head, ICMR-WHO Research and Training Centre in Immunology for India and South East Asia (1972–91). He was the founding director of the National Institute of Immunology (NII) (1983–91) and also professor of eminence till 1994. He was professor of eminence and senior consultant, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi (1994–99) and director research, Talwar Research Foundation, New Delhi (2000- ). He was visiting professor, College de France (1991), Wellcome Professor at Johns Hopkins (1994–95), and distinguished professor at the Institute of Bioinformatics and Biotechnology, University of Pune (2005–10).[7]

Awards

References

  1. ^ Aggarwala, Dharma Vira; Singh, Gurbachan (1972). All India Educational Directory. All India Directories Publishers. p. 1085.
  2. ^ Raghunath, Ranjini (2024). "The Industrious Immunologist" (PDF). Connect. 11 (4): 44–48.
  3. ^ a b Mukerjee, Madhusree (1996). "Pushing the Envelope for Vaccines". Scientific American. 275 (1): 38–40. Bibcode:1996SciAm.275a..38M. doi:10.1038/scientificamerican0796-38. PMID 8658109.
  4. ^ Dogra, Sunil; Jain, Sejal; Sharma, Ayush; Chhabra, Seema; Narang, Tarun (2023). "Mycobacterium Indicus Pranii (MIP) Vaccine: Pharmacology, Indication, Dosing Schedules, Administration, and Side Effects in Clinical Practice". Indian Dermatology Online Journal. 14 (6): 753–761. doi:10.4103/idoj.idoj_360_23. ISSN 2229-5178. PMC 10718117. PMID 38099011.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  5. ^ Balasubramanian, D. (15 April 2017). "Talwar's talwar against leprosy, TB and cancer". The Hindu. ISSN 0971-751X. Retrieved 9 July 2025.
  6. ^ Talwar, G. P.; Singh, Om; Pal, Rahul; Chatterjee, N.; Sahai, P.; Dhall, Kamala; Kaur, Jasvinder; Das, S. K.; et al. (1994). "A Vaccine that Prevents Pregnancy in Women". Proceedings of the National Academy of Sciences. 91 (18): 8532–6. Bibcode:1994PNAS...91.8532T. doi:10.1073/pnas.91.18.8532. JSTOR 2365427. PMC 44640. PMID 8078917.
  7. ^ Aldhous, Peter (1994). "A booster for contraceptive vaccines". Science. 266 (5190): 1484–6. Bibcode:1994Sci...266.1484A. doi:10.1126/science.7985014. PMID 7985014.
  8. ^ "Prof. G. P. Talwar, Former Director, NII". Archived from the original on 21 January 2015. Retrieved 21 January 2015.
  9. ^ "INSA". Archived from the original on 21 January 2015. Retrieved 21 January 2015.


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.